Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infectivity of New P. falciparum Lot in CHMI Model
NCT03882528Phase 1Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Mar 2019
- Primary completion
- Apr 2019
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in malaria, sponsored by U.S. Army Medical Research and Development Command. Primary endpoint: Characterize the Infectivity of a New Lot of Plasmodium Falciparum Strain 3D7 Developing Parasitemia at 2 weeks. Started Mar 2019; status: completed.
02
Conditions
malaria
Beyond the preview
Go deeper on NCT03882528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03882528.